| Knowledge source name |
Stem Cells for Drug Discovery |
| Abbreviated name |
StemBANCC |
| Owner/Developer |
Innovative Medicines Initiative |
| Abbreviated owner |
IMI |
| Country |
Switzerland |
| Languages |
English |
| URL |
http://stembancc.org/ |
| Contact |
http://stembancc.org/index.php?option=com_contact&view=contact&id=1&Itemid=108 |
| Description |
StemBANCC is a large-scale, 5 year academic-industry partnership in the area of stem cell research. It brings a consortium of 35 partners together who share their experience and collaborate in 12 work packages. It is a collaborative project between pharmaceutical companies, research institutions and small and medium enterprises (SMEs) to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry for patient benefit. StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders. |